AIM
AIM ImmunoTech
14 hedge funds and large institutions have $2.57M invested in AIM ImmunoTech in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$39K | |
| 2 | +$27.3K | |
| 3 | +$7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.5K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.5K |
Top Sellers
| 1 | -$164K | |
| 2 | -$24.2K | |
| 3 | -$13K | |
| 4 |
Renaissance Technologies
New York
|
-$12.1K |
| 5 |
CHC
City Holding Co
Charleston,
West Virginia
|
-$1K |